This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Genetic Technologies Ltd (GENE)

: Services

Company Income Statement
Jun 2015 Jun 2014 Jun 2013 Jun 2012
Sales 2.33M 5.22M 7.78M 11.60M
Cost of Sales 505.48K 1.41M 1.44M 1.42M
Gross Operating Profit 1.83M 3.81M 6.34M 10.18M
Selling, General, and Administrative Expenses 7.03M 9.89M 11.21M 11.53M
Research & Development 2.19M 3.11M 3.21M 4.13M
Operating Income before D & A (EBITDA) -7.39M -9.19M -8.08M -5.47M
Depreciation & Amortization 178.10K 318.64K 369.59K 575.49K
Interest Income 30.64K 0.00 0.00 624.50K
Other Income - Net 982.62K 1.01M 218.51K 46.75K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -6.55M -8.84M -8.64M -5.38M
Interest Expense 203.02K 700.66K 36.16K 46.31K
Pre-Tax Income -6.76M -9.54M -8.68M -5.42M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 -8.73K -47.43K -9.53K
Net Income From Continuing Operations -6.76M -9.54M -8.68M -5.42M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -6.76M -9.54M -8.68M -5.42M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -6.76M -9.53M -8.63M -5.41M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-6.76M -9.54M -8.68M -5.42M
Preferred Dividends
Net Income Available To Common -6.76M -9.54M -8.68M -5.42M
Basic EPS from Continuing Ops. -0.94 -2.49 -2.74 -1.76
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.94 -2.49 -2.74 -1.76
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.94 -2.49 -2.74 -1.77
Basic Normalized Net Income/Share -0.94 -2.49 -2.74 -1.76
EPS fr Continuing Ops. -0.94 -2.49 -2.74 -1.76
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.94 -2.49 -2.74 -1.76
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.94 -2.49 -2.74 -1.77
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.94 -2.49 -2.74 -1.76
Dividends Paid per Share 0.00 0.00 0.00 0.00
GENE News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

GENE Genetic Technologies Ltd

Chart of GENE

Analysts Ratings for GENE

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 0 0 0 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET GENE ANALYST REPORT

GENE Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs